Journal of Ophthalmic and Vision Research

Published date: Jun 18 2025

Journal Title: Journal of Ophthalmic and Vision Research

Issue title: ‎Volume 20 - 2025

Pages: 1 - 8

DOI: 10.18502/jovr.v20.17499

Samir Malhotrasmalhot2@uci.eduDepartment of Biomedical Engineering, University of California, Irvine, Irvine, CA

Magdalene J. Seilermseiler@hs.uci.eduSue & Bill Gross Stem Cell Research Center, University of California, Irvine, Irvine, CA

Andrew W. Browneabrowne1@hs.uci.eduDepartment of Biomedical Engineering, University of California, Irvine, Irvine

Retinal degenerative diseases (RDD), which impair photoreceptors, the retinal pigment epithelium (RPE), and associated retinal cells, result in severe vision loss. For patients with advanced RDD, tissue replacement therapies, such as transplantation, offer potential pathways to visual rehabilitation. While fetal retinal transplantation has shown some promise in preclinical and clinical studies, human pluripotent stem cell (hPSC)-derived retinal organoids (ROs) present a promising alternative. ROs are three-dimensional tissues that replicate key aspects of retinal development, making them viable candidates for transplantation. However, the path toward clinical application faces two primary challenges: achieving Good Manufacturing Practice (GMP)- compliant production and overcoming technical difficulties associated with safe transplantation. Current RO production protocols are often limited by variability in tissue morphology, yield, and reproducibility, while transplantation efforts are hindered by rosette formation and mechanical damage to the subretinal space. Recent innovations, including automated bioreactor systems and optimized surgical techniques, offer potential solutions. Further advances in understanding and preventing rosette formation are essential to improve transplantation outcomes. Continued research and technological development are necessary to unlock the full potential of ROs for visual rehabilitation in patients with retinal degeneration.

Keywords: Photoreceptors, Pluripotent Stem Cells, Regenerative Medicine, Retinal Degeneration, Retinal Organoids, Retinal Transplantation

1. Radtke ND, Aramant RB, Petry HM, Green PT, Pidwell DJ, Seiler MJ. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol 2008;146:172–182.

2. Seiler MJ, Lin RE, McLelland BT, Mathur A, Lin B, Sigman J, et al. Vision recovery and connectivity by fetal retinal sheet transplantation in an immunodeficient retinal degenerate rat model. Invest Ophthalmol Vis Sci 2017;58:614–630.

3. Seiler MJ, Aramant RB. Cell replacement and visual restoration by retinal sheet transplants. Prog Retin Eye Res 2012;31:661–687.

4. Lin B, McLelland BT, Mathur A, Aramant RB, Seiler MJ. Sheets of human retinal progenitor transplants improve vision in rats with severe retinal degeneration. Exp Eye Res 2018;174:13–28.

5. Drag S, Dotiwala F, Upadhyay AK. Gene therapy for retinal degenerative diseases: Progress, challenges, and future directions. Invest Ophthalmol Vis Sci 2023;64:39.

6. McLelland BT, Lin B, Mathur A, Aramant RB, Thomas BB, Nistor G, et al. Transplanted hESC-derived retina organoid sheets differentiate, integrate, and improve visual function in retinal degenerate rats. Invest Ophthalmol Vis Sci 2018;59:2586–2603.

7. Lin B, McLelland BT, Aramant RB, Thomas BB, Nistor G, Keirstead HS, et al. Retina organoid transplants develop photoreceptors and improve visual function in RCS rats with RPE dysfunction. Invest Ophthalmol Vis Sci 2020;61:34.

8. Lin B, Singh RK, Seiler MJ, Nasonkin IO. Survival and functional integration of human embryonic stem cell-derived retinal organoids after shipping and transplantation into retinal degeneration rats. Stem Cells Dev 2024;33:201–213.

9. Eiraku M, Sasai Y. Mouse embryonic stem cell culture for generation of three-dimensional retinal and cortical tissues. Nat Protoc 2011;7:69–79.

10. Nakano T, Ando S, Takata N, Kawada M, Muguruma K, Sekiguchi K, et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 2012;10:771–785.

11. Li X, Zhang L, Tang F, Wei X. Retinal organoids: Cultivation, differentiation, and transplantation. Front Cell Neurosci 2021;15:638439.

12. Llonch S, Carido M, Ader M. Organoid technology for retinal repair. Dev Biol 2018;433:132–143.

13. Jayakody SA, Gonzalez-Cordero A, Ali RR, Pearson RA. Cellular strategies for retinal repair by photoreceptor replacement. Prog Retin Eye Res 2015;46:31–66.

14. Matsushita T, Onishi A, Matsuyama T, Masuda T, Ogino Y, Kageyama M, et al. Rapid and efficient generation of mature retinal organoids derived from human pluripotent stem cells via optimized pharmacological modulation of Sonic hedgehog, activin A, and retinoic acid signal transduction. PLoS One 2024;19:e0308743.

15. Sanjurjo-Soriano C, Erkilic N, Damodar K, Boukhaddaoui H, Diakatou M, Garita-Hernandez M, et al. Retinoic acid delays initial photoreceptor differentiation and results in a highly structured mature retinal organoid. Stem Cell Res Ther 2022;13:478.

16. Wahlin KJ, Maruotti JA, Sripathi SR, Ball J, Angueyra JM, Kim C, et al. Photoreceptor outer segment-like structures in long-term 3D retinas from human pluripotent stem cells. Sci Rep 2017;7:766.

17. Wagstaff EL, Heredero Berzal A, Boon CJ, Quinn PM, Ten Asbroek AL, Bergen AA. The role of small molecules and their effect on the molecular mechanisms of early retinal organoid development. Int J Mol Sci 2021;22:7081.

18. Chakrabarty K, Nayak D, Debnath J, Das D, Shetty R, Ghosh A. Retinal organoids in disease modeling and drug discovery: Opportunities and challenges. Surv Ophthalmol 2024;69:179–189.

19. Harkin J, Peña KH, Gomes C, Hernandez M, Lavekar SS, So K, et al. A highly reproducible and efficient method for retinal organoid differentiation from human pluripotent stem cells. Proc Natl Acad Sci USA 2024;121:e2317285121.

20. Isla-Magrané H, Zufiaurre-Seijo M, García-Arumí J, Duarri A. All-trans retinoic acid modulates pigmentation, neuroretinal maturation, and corneal transparency in human multiocular organoids. Stem Cell Res Ther 2022;13:376.

21. Kelley RA, Chen HY, Swaroop A, Li T. Accelerated development of rod photoreceptors in retinal organoids derived from human pluripotent stem cells by supplementation with 9-cis retinal. STAR Protoc 2020;1:100033.

22. Cobb H, Aparicio-Domingo S, Canto-Soler MV. Transitioning into GMP-compliance: Alternative methods for producing retinal organoids for transplantation. Transl Vis Sci Technol 2021;10:9.

23. Regent F, Chen HY, Kelley RA, Qu Z, Swaroop A, Li T. A simple and efficient method for generating human retinal organoids. Mol Vis 2020;26:97–105.

24. Xue Y, Seiler MJ, Tang WC, Wang JY, Delgado J, McLelland BT, et al. Retinal organoids on-a-chip: A micro-millifluidic bioreactor for long-term organoid maintenance. Lab Chip 2021;21:3361–3377.

25. Xue Y, Browne AW, Tang WC, Delgado J, McLelland BT, Nistor G, et al. Retinal organoids long-term functional characterization using two-photon fluorescence lifetime and hyperspectral microscopy. Front Cell Neurosci 2021;15:796903.

26. Watari K, Yamasaki S, Tu HY, Shikamura M, Kamei T, Adachi H, et al. Self-organization, quality control, and preclinical studies of human iPSC-derived retinal sheets for tissue-transplantation therapy. Commun Biol 2023;6:164.

27. Hirami Y, Mandai M, Sugita S, Maeda A, Maeda T, Yamamoto M, et al. Safety and stable survival of stemcell- derived retinal organoid for 2 years in patients with retinitis pigmentosa. Cell Stem Cell 2023;30:1585–1596.e6.

28. Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, et al. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration. Sci Transl Med 2018;10:eaao4097.29. Schwartz SD, Tan G, Hosseini H, Nagiel A. Subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium for the treatment of macular degeneration: An assessment at 4 years. Invest Ophthalmol Vis Sci 2016;57:ORSFc1-9.

30. Miyake M, Nakao SY, Morino K, Yasukura S, Mori Y, Ishihara K, et al.; Japan-Retinal Detachment Registry Group. Effect of duration of macular detachment on visual prognosis after surgery for macula-off retinal detachment: Japan-Retinal Detachment Registry. Ophthalmol Retina 2023;7:375–382.

31. Thomas BB, Lin B, Martinez-Camarillo JC, Zhu D, McLelland BT, Nistor G, et al. Co-grafts of human embryonic stem cell derived retina organoids and retinal pigment epithelium for retinal reconstruction in immunodeficient retinal degenerate royal college of surgeons rats. Front Neurosci 2021;15:752958.

32. Ishikura M, Muraoka Y, Hirami Y, Tu HY, Mandai M. Adaptive optics optical coherence tomography analysis of induced pluripotent stem cell-derived retinal organoid transplantation in retinitis pigmentosa. Cureus 2024;16:e64962.

33. Matsuyama T, Tu HY, Sun J, Hashiguchi T, Akiba R, Sho J, et al. Genetically engineered stem cell-derived retinal grafts for improved retinal reconstruction after transplantation. iScience 2021;24:102866.

34. Yamasaki S, Tu HY, Matsuyama T, Horiuchi M, Hashiguchi T, Sho J, et al. A genetic modification that reduces ON-bipolar cells in hESC-derived retinas enhances functional integration after transplantation. iScience 2021;25:103657.